Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LANCL2 | Q9NS86 | 1/20 | 0.93 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.49 |
| ▸ | GNE | Q9Y223 | 1/20 | 0.47 |
| ▸ | ATR | Q13535 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.45 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | PKM | P14618 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Omilancor SCHEMBL29349469 | 0.96 | LANCL2 (1.00) | LANCL2MEN1KMT2AHRH4GNE | |
| Omilancor SCHEMBL17706588 | 0.96 | LANCL2 (1.00) | LANCL2MEN1KMT2AHRH4GNE | |
| SCHEMBL18805072 | 0.95 | LANCL2 (0.88) | LANCL2MEN1KMT2AHRH4GNE | |
| SCHEMBL17705594 | 0.90 | LANCL2 (0.88) | LANCL2MEN1KMT2AHRH4ATR | |
| SCHEMBL29466338 | 0.89 | LANCL2 (0.86) | LANCL2MEN1KMT2AHRH4GNE | |
| SCHEMBL25877375 | 0.89 | LANCL2 (0.86) | LANCL2MEN1KMT2AHRH4GNE | |
| SCHEMBL29063415 | 0.88 | LANCL2 (0.84) | LANCL2MEN1KMT2AHRH4ATR | |
| SCHEMBL25881521 | 0.88 | LANCL2 (0.76) | LANCL2MEN1KMT2AHRH4GNE | |
| SCHEMBL23561738 | 0.88 | LANCL2 (0.83) | LANCL2MEN1KMT2AHRH4HPGD | |
| SCHEMBL25877794 | 0.87 | LANCL2 (0.82) | LANCL2MEN1KMT2AHRH4ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11197891-B2 | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith | LANDOS BIOPHARMA, INC. (US) | 2021-12-14 | — | — | US | disclosed |
| US-20190160100-A1 | THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH | LANDOS BIOPHARMA, INC. (US) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190160100-A1 | THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH | LCP2, LANCL2, CALCB | LANCL2 2/4885MEN1 2022/4885KMT2A 3249/4885 |
| US-11197891-B2 | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith | LCP2, LANCL2, CALCB | LANCL2 2/4885MEN1 2022/4885KMT2A 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.